India's pharmaceutical industry is urging its government to negotiate with Washington from a “position of power” on tariffs ...

India has emerged as a growing player in the illicit fentanyl trade, a new US intelligence report says, a designation likely ...

The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.

India has emerged as an increasingly significant player in the illicit fentanyl trade, according to a new intelligence report ...

Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, although a decline in Tata Motors ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

Warns that Indian pharmaceutical products could become more expensive in the US, reducing their competitiveness in one of the ...

U.S. President Trump imposes 25% tariff on auto imports, spotlight on pharma imports, Indian industry at risk.

Former Pharmexcil Director-General warns India against reducing import duties under US pressure, citing potential industry ...

Trump told reporters that he may give a lot of countries “breaks” from his reciprocal tariff move, without giving details.

The Department of Pharmaceuticals, Government of India, hosted an Industry Dialogue on the scheme for Promotion of Research ...